Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP740608.RAu3ATinHkZOTwuDWlRLPMxTEjYpvJgUT4ZkwC2XXPC_4130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740608.RAu3ATinHkZOTwuDWlRLPMxTEjYpvJgUT4ZkwC2XXPC_4130_provenance.
• NP302324.RArAuAvga7PTa-qCwDRZms8HZXS-SJ5OTnbrqAF_xJJLs130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302324.RArAuAvga7PTa-qCwDRZms8HZXS-SJ5OTnbrqAF_xJJLs130_provenance.
• NP376477.RAnYZFiutA2ycLNf4VPY4B99FV-GRIKwUJQjRs0KmLiWI130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376477.RAnYZFiutA2ycLNf4VPY4B99FV-GRIKwUJQjRs0KmLiWI130_provenance.
• NP268770.RABzt3IU5cJ-u37aLsVoFSoPCo6Dkzm5STOD2VPpcMYTw130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268770.RABzt3IU5cJ-u37aLsVoFSoPCo6Dkzm5STOD2VPpcMYTw130_provenance.
• NP870429.RAqgjNcALgB75mwhaudwB5_R6lnypUp6KYp8JdVRVgrGE130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870429.RAqgjNcALgB75mwhaudwB5_R6lnypUp6KYp8JdVRVgrGE130_provenance.
• NP676470.RARVLHVSTtfEKslD2uCc9m00EncvwD1Y74rzkpqDKZtjA130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676470.RARVLHVSTtfEKslD2uCc9m00EncvwD1Y74rzkpqDKZtjA130_provenance.
• NP169924.RAEJg2KG946NnGn0PaKsIPjKxXGhwt-NUPQhJWv4Y_678130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169924.RAEJg2KG946NnGn0PaKsIPjKxXGhwt-NUPQhJWv4Y_678130_provenance.
• NP701466.RA7ATFQ_EGTbP0Mdlx6Hyz6MSwqBeyHGb_tgBBQe4iAVg130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP701466.RA7ATFQ_EGTbP0Mdlx6Hyz6MSwqBeyHGb_tgBBQe4iAVg130_provenance.
• NP757320.RATJp7px9qZ7JiP_vqpE3XvfDLiZgLqpXjjCeGWuR02b8130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757320.RATJp7px9qZ7JiP_vqpE3XvfDLiZgLqpXjjCeGWuR02b8130_provenance.
• NP622617.RARnRXYH-hIwKlS-y0ZopokDNUG0iExu_4K5L4HTHak7o130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622617.RARnRXYH-hIwKlS-y0ZopokDNUG0iExu_4K5L4HTHak7o130_provenance.
• NP622945.RAWzYFiQSthoh8beATU-On_BawUEI5DiclsJddsnvRg5w130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622945.RAWzYFiQSthoh8beATU-On_BawUEI5DiclsJddsnvRg5w130_provenance.
• NP623929.RAZWxdLNOODFBhyx7YDfe09dPjDjgY4BqTUj-j-RpOQPY130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623929.RAZWxdLNOODFBhyx7YDfe09dPjDjgY4BqTUj-j-RpOQPY130_provenance.
• NP624261.RAW9GIeRM2V7F_GBbUhJ7oZindGz6irEz2duyAOpRU-QA130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624261.RAW9GIeRM2V7F_GBbUhJ7oZindGz6irEz2duyAOpRU-QA130_provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP858732.RAKrz6tckAeH9LypYlX9KrrSSk1s6KD6lqXX6xcNNTkRE130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858732.RAKrz6tckAeH9LypYlX9KrrSSk1s6KD6lqXX6xcNNTkRE130_provenance.
• NP1033117.RABw5eWY_t_yonhFItArNr10ie75pDXlzS4tL7cr1TxQc130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033117.RABw5eWY_t_yonhFItArNr10ie75pDXlzS4tL7cr1TxQc130_provenance.
• NP848840.RAKHnkkA9LqhUdUcO1EjNYNObDNP16miT6tSNemzmvH7Y130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848840.RAKHnkkA9LqhUdUcO1EjNYNObDNP16miT6tSNemzmvH7Y130_provenance.
• NP1033118.RAuPui_oD5IOPkO_Ea_gqoP0VOotrozhExUi9admlK3h8130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033118.RAuPui_oD5IOPkO_Ea_gqoP0VOotrozhExUi9admlK3h8130_provenance.
• NP1033119.RArJcT-jeOssgZxWXRCAHtPHPRzJxFYsutphP7GaoGFAI130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033119.RArJcT-jeOssgZxWXRCAHtPHPRzJxFYsutphP7GaoGFAI130_provenance.
• NP1033121.RAgmB9KMRoO-qCvburrRInw5lDAYHblRxWkbnhPGBPHFo130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033121.RAgmB9KMRoO-qCvburrRInw5lDAYHblRxWkbnhPGBPHFo130_provenance.
• NP1033122.RAjSG0eg4ifo6uLVrxIQrGKFzxrU8KGJ2rPURDUeeEuvQ130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033122.RAjSG0eg4ifo6uLVrxIQrGKFzxrU8KGJ2rPURDUeeEuvQ130_provenance.
• NP1033123.RAtcKYmQi3sfgBp8gUsDGWJLwaH5B7v5tnX7w9YagjsRU130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033123.RAtcKYmQi3sfgBp8gUsDGWJLwaH5B7v5tnX7w9YagjsRU130_provenance.
• NP1033125.RAiU1W7_va0JfdrDv-Q2HJHiLdqzj76EfYReyjg3qf250130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033125.RAiU1W7_va0JfdrDv-Q2HJHiLdqzj76EfYReyjg3qf250130_provenance.
• NP625401.RAIvAuX_jcK1-68_EkjNU0AaBCOtK9RwDIFTXfqdZR9c0130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625401.RAIvAuX_jcK1-68_EkjNU0AaBCOtK9RwDIFTXfqdZR9c0130_provenance.
• NP621223.RA3D2JwwC_ojR7k326f7vFIYPHi63bJjdVFvcB_mEeOes130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621223.RA3D2JwwC_ojR7k326f7vFIYPHi63bJjdVFvcB_mEeOes130_provenance.
• NP621699.RA6PIuKsHTnEzvWNAyno7ct5UTaRU2w7EpH9DLjrngx0c130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621699.RA6PIuKsHTnEzvWNAyno7ct5UTaRU2w7EpH9DLjrngx0c130_provenance.
• NP625069.RA-65Dc6HiyL7TbhxFNgjwvsiOKL_fLW-drF0fnDseYl8130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625069.RA-65Dc6HiyL7TbhxFNgjwvsiOKL_fLW-drF0fnDseYl8130_provenance.
• NP757344.RA49Kvz-mkHuKjUvIlJLN25NFfu625PWBjNCPiE3B6Gd8130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757344.RA49Kvz-mkHuKjUvIlJLN25NFfu625PWBjNCPiE3B6Gd8130_provenance.
• NP1033128.RAL4WxhagH0DZWNWC0NVRtQrv2se68GZEs8WBZmeU8zhA130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033128.RAL4WxhagH0DZWNWC0NVRtQrv2se68GZEs8WBZmeU8zhA130_provenance.
• NP1033116.RA4JR01s5x3ldcyRDcBtfx3eV43WiHrmZKvIQcIODTr3c130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033116.RA4JR01s5x3ldcyRDcBtfx3eV43WiHrmZKvIQcIODTr3c130_provenance.
• NP1033126.RAzim7K7Qzc3vUChKPvKPOWxIJ0Wl78HjW4g0EmUxZg1Y130_assertion description "[Hsp90B1 is a direct target of miR-223 and miR- 223 may have a tumor suppressor function in osteosarcoma through the PI3K/Akt/mTOR pathway and could be used in anticancer therapies in osteosarcoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1033126.RAzim7K7Qzc3vUChKPvKPOWxIJ0Wl78HjW4g0EmUxZg1Y130_provenance.